Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice. / Jähn, Katharina; Saito, Hiroaki; Taipaleenmäki, Hanna et al.
in: Acta Biomaterialia, Jahrgang 36, 01.05.2016, S. 350-360.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

Jähn, K, Saito, H, Taipaleenmäki, H, Gasser, A, Hort, N, Feyerabend, F, Schlüter, H, Rueger, JM, Lehmann, W, Willumeit-Römer, R & Hesse, E 2016, 'Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice', Acta Biomaterialia, Jg. 36, S. 350-360. https://doi.org/10.1016/j.actbio.2016.03.041

APA

Jähn, K., Saito, H., Taipaleenmäki, H., Gasser, A., Hort, N., Feyerabend, F., Schlüter, H., Rueger, J. M., Lehmann, W., Willumeit-Römer, R., & Hesse, E. (2016). Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice. Acta Biomaterialia, 36, 350-360. https://doi.org/10.1016/j.actbio.2016.03.041

Vancouver

Jähn K, Saito H, Taipaleenmäki H, Gasser A, Hort N, Feyerabend F et al. Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice. Acta Biomaterialia. 2016 Mai 1;36:350-360. doi: 10.1016/j.actbio.2016.03.041

Bibtex

@article{6ef0ed2d4dca497fb268925335612f24,
title = "Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice",
abstract = "Intramedullary stabilization is frequently used to treat long bone fractures. Implants usually remain unless complications arise. Since implant removal can become technically very challenging with the potential to cause further tissue damage, biodegradable materials are emerging as alternative options. Magnesium (Mg)-based biodegradable implants have a controllable degradation rate and good tissue compatibility, which makes them attractive for musculoskeletal research. Here we report for the first time the implantation of intramedullary nails made of an Mg alloy containing 2% silver (Mg2Ag) into intact and fractured femora of mice. Prior in vitro analyses revealed an inhibitory effect of Mg2Ag degradation products on osteoclast differentiation and function with no impair of osteoblast function. In vivo, Mg2Ag implants degraded under non-fracture and fracture conditions within 210 days and 133 days, respectively. During fracture repair, osteoblast function and subsequent bone formation were enhanced, while osteoclast activity and bone resorption were decreased, leading to an augmented callus formation. We observed a widening of the femoral shaft under steady state and regenerating conditions, which was at least in part due to an uncoupled bone remodeling. However, Mg2Ag implants did not cause any systemic adverse effects. These data suggest that Mg2Ag implants might be promising for intramedullary fixation of long bone fractures, a novel concept that has to be further investigated in future studies. Statement of Significance Biodegradable implants are promising alternatives to standard steel or titanium implants to avoid implant removal after fracture healing. We therefore developed an intramedullary nail using a novel biodegradable magnesium-silver-alloy (Mg2Ag) and investigated the in vitro and in vivo effects of the implants on bone remodeling under steady state and fracture healing conditions in mice. Our results demonstrate that intramedullary Mg2Ag nails degrade in vivo over time without causing adverse effects. Importantly, radiographs, μCT and bone histomorphometry revealed a significant increase in callus size due to an augmented bone formation rate and a reduced bone resorption in fractures supported by Mg2Ag nails, thereby improving bone healing. Thus, intramedullary Mg2Ag nails are promising biomaterials for fracture healing to circumvent implant removal.",
keywords = "Biodegradation, Bone healing, Callus formation, Intramedullary fracture fixation, Mg2Ag alloy, Engineering",
author = "Katharina J{\"a}hn and Hiroaki Saito and Hanna Taipaleenm{\"a}ki and Andreas Gasser and Norbert Hort and Frank Feyerabend and Hartmut Schl{\"u}ter and Rueger, {Johannes M.} and Wolfgang Lehmann and Regine Willumeit-R{\"o}mer and Eric Hesse",
year = "2016",
month = may,
day = "1",
doi = "10.1016/j.actbio.2016.03.041",
language = "English",
volume = "36",
pages = "350--360",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier B.V.",

}

RIS

TY - JOUR

T1 - Intramedullary Mg2Ag nails augment callus formation during fracture healing in mice

AU - Jähn, Katharina

AU - Saito, Hiroaki

AU - Taipaleenmäki, Hanna

AU - Gasser, Andreas

AU - Hort, Norbert

AU - Feyerabend, Frank

AU - Schlüter, Hartmut

AU - Rueger, Johannes M.

AU - Lehmann, Wolfgang

AU - Willumeit-Römer, Regine

AU - Hesse, Eric

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Intramedullary stabilization is frequently used to treat long bone fractures. Implants usually remain unless complications arise. Since implant removal can become technically very challenging with the potential to cause further tissue damage, biodegradable materials are emerging as alternative options. Magnesium (Mg)-based biodegradable implants have a controllable degradation rate and good tissue compatibility, which makes them attractive for musculoskeletal research. Here we report for the first time the implantation of intramedullary nails made of an Mg alloy containing 2% silver (Mg2Ag) into intact and fractured femora of mice. Prior in vitro analyses revealed an inhibitory effect of Mg2Ag degradation products on osteoclast differentiation and function with no impair of osteoblast function. In vivo, Mg2Ag implants degraded under non-fracture and fracture conditions within 210 days and 133 days, respectively. During fracture repair, osteoblast function and subsequent bone formation were enhanced, while osteoclast activity and bone resorption were decreased, leading to an augmented callus formation. We observed a widening of the femoral shaft under steady state and regenerating conditions, which was at least in part due to an uncoupled bone remodeling. However, Mg2Ag implants did not cause any systemic adverse effects. These data suggest that Mg2Ag implants might be promising for intramedullary fixation of long bone fractures, a novel concept that has to be further investigated in future studies. Statement of Significance Biodegradable implants are promising alternatives to standard steel or titanium implants to avoid implant removal after fracture healing. We therefore developed an intramedullary nail using a novel biodegradable magnesium-silver-alloy (Mg2Ag) and investigated the in vitro and in vivo effects of the implants on bone remodeling under steady state and fracture healing conditions in mice. Our results demonstrate that intramedullary Mg2Ag nails degrade in vivo over time without causing adverse effects. Importantly, radiographs, μCT and bone histomorphometry revealed a significant increase in callus size due to an augmented bone formation rate and a reduced bone resorption in fractures supported by Mg2Ag nails, thereby improving bone healing. Thus, intramedullary Mg2Ag nails are promising biomaterials for fracture healing to circumvent implant removal.

AB - Intramedullary stabilization is frequently used to treat long bone fractures. Implants usually remain unless complications arise. Since implant removal can become technically very challenging with the potential to cause further tissue damage, biodegradable materials are emerging as alternative options. Magnesium (Mg)-based biodegradable implants have a controllable degradation rate and good tissue compatibility, which makes them attractive for musculoskeletal research. Here we report for the first time the implantation of intramedullary nails made of an Mg alloy containing 2% silver (Mg2Ag) into intact and fractured femora of mice. Prior in vitro analyses revealed an inhibitory effect of Mg2Ag degradation products on osteoclast differentiation and function with no impair of osteoblast function. In vivo, Mg2Ag implants degraded under non-fracture and fracture conditions within 210 days and 133 days, respectively. During fracture repair, osteoblast function and subsequent bone formation were enhanced, while osteoclast activity and bone resorption were decreased, leading to an augmented callus formation. We observed a widening of the femoral shaft under steady state and regenerating conditions, which was at least in part due to an uncoupled bone remodeling. However, Mg2Ag implants did not cause any systemic adverse effects. These data suggest that Mg2Ag implants might be promising for intramedullary fixation of long bone fractures, a novel concept that has to be further investigated in future studies. Statement of Significance Biodegradable implants are promising alternatives to standard steel or titanium implants to avoid implant removal after fracture healing. We therefore developed an intramedullary nail using a novel biodegradable magnesium-silver-alloy (Mg2Ag) and investigated the in vitro and in vivo effects of the implants on bone remodeling under steady state and fracture healing conditions in mice. Our results demonstrate that intramedullary Mg2Ag nails degrade in vivo over time without causing adverse effects. Importantly, radiographs, μCT and bone histomorphometry revealed a significant increase in callus size due to an augmented bone formation rate and a reduced bone resorption in fractures supported by Mg2Ag nails, thereby improving bone healing. Thus, intramedullary Mg2Ag nails are promising biomaterials for fracture healing to circumvent implant removal.

KW - Biodegradation

KW - Bone healing

KW - Callus formation

KW - Intramedullary fracture fixation

KW - Mg2Ag alloy

KW - Engineering

UR - http://www.scopus.com/inward/record.url?scp=84962019429&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/1b952cc2-0b3b-38a1-a524-b49fb3dd4d1c/

U2 - 10.1016/j.actbio.2016.03.041

DO - 10.1016/j.actbio.2016.03.041

M3 - Journal articles

C2 - 27039975

AN - SCOPUS:84962019429

VL - 36

SP - 350

EP - 360

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -

DOI